Pavlos Msaouel: Methodological challenges and solutions in estimating os from Randomized Controlled Trials
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a post on X about recent paper by him as co-author, titled “Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting” published on Science Direct.
Authors: Stephanie A. Berg, Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albiges, Kathryn E. Beckermann, Matthew T. Campbell, Maria I. Carlo, Katie Coleman, Daniel J. George, Daniel M. Geynisman, Ritchie Johnson, Eric Jonasch, Jodi K. Maranchie, Bradley A. McGregor, Daniel D. Shapiro, Eric A. Singer, Brian M. Shuch, Walter M. Stadler, Nizar M. Tannir, Yousef Zakharia, Ulka N. Vaishampayan, Peter F. Thall, Pavlos Msaouel.
“The Think Tank summary is out discussing methodological challenges and solutions in estimating overall survival from Randomized Controlled Trials when subsequent therapies are available.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023